We investigate peptide vendors so buyers don't have to gamble.
Transparent, accountable supply chains make peptides and other research compounds safer for the public. VendorInvestigate exists to force that transparency onto a market that runs on trust and offers almost none of it.
Our Mission
VendorInvestigate is an independent bureau that lab-tests the peptide vendors the public actually buys from, then publishes what it finds as open case files.
As more people take their health into their own hands, many end up ordering from sellers that offer no transparency, no accountability and no recourse — taking on risk they have no way to measure.
Our job is to measure it for them: procure blind, test independently, and put every finding on the record — the flattering and the damning alike.
Transparency
We grade and rank subjects on real laboratory results, never on marketing, so a buyer can read a verdict at a glance.
Accountability
We test the same products from multiple sources, independently checking what vendors and their own labs claim. Where the vial disagrees with the label, the disagreement goes in the file.
The Record
We are building an open, community-fed record where every case file funded by one buyer protects the next. Nothing is quietly deleted; corrections are posted in the open.
How the Bureau Works
Free community testing
Anyone can submit a vial as evidence, at no charge. These public submissions are the lifeblood of the record and let us keep a broad, current read on the market.
We also procure our own samples blind, directly from vendors at retail, so our findings never depend on what a subject chooses to hand us. The two streams together give the most reliable picture possible.
Every result enters a public index that grades subjects and compounds on measured quality — imposing scrutiny on a market that has dodged it for years.
What the Bureau doesn't do
- Sell peptides, or any other compound
- Provide medical advice or recommendations
- Publish vendor-supplied testing as though it were our own work
- Accept payment to change, soften or remove a verdict
The Bureau
Michael Carter
Chairman
Serial entrepreneur on a personal mission to make sovereign health safer.
Raphaël Mazoyer
Chief Executive Officer
Leads the bureau to build trust where, today, almost none exists.
Stephanie Adamson King
Policy & Platforms
Maximises impact through strategic partnerships and policy initiatives.
Who Backs the Bureau
We are proud to be backed by individuals who believe in making sovereign health safer through transparency and accountability.
Our investors understand how much a reliable supply chain matters, and they support our vision for a market where quality is visible and rewarded.
- Naval Ravikant
- Gary Ang
- Josh Buckley
- Teddy Cross
- Tom Fairfield
- Jacob Jacquet
- Walter Kortschak
- Richard Ma
- Ken O'Friel
- Michael Piech
- Lim Qing Ru
- Craig Schmitz
- Jeremy Siong
- Siddhartha Shekhar Singh
- Dominika Stobiecka
- Cameron Teitelman
Pitch In
Help us hold the market to account: submit a vial as evidence to our Austin, TX intake. It is completely free. (US shipments only.)